Back to LYEL
Ikarian Capital, LLC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
4
Latest value
$402K
Q3 2026
Peak value
$1.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.3M |
| Q1 2026 | $824K |
| Q2 2026 | $577K |
| Q3 2026 | $402K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $402K | 41.1K | — | — |
| Q2 2026 | $577K | 41.1K | — | — |
| Q1 2026 | $824K | 41.1K | — | — |
| Q4 2025 | $1.3M | 41.1K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M